What are the responsibilities and job description for the Vice President, Head of Development Neurodegeneration position at Johnson and Johnson?
At Johnson & Johnson, we believe health is everything.
Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal.
Through our expertise in Pharmaceuticals and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
Learn more at https : / / www.jnj.com / . The Johnson & Johnson Credo Our Credo was created by J&J Chairman Robert Wood Johnson in 1943, well before the concept of corporate social responsibility had been established.
The driving force behind Johnson & Johnson is that our current business strategy is rooted in the four principles of the original J&J Credo.
Robert Wood Johnson believed that "the Credo is more than just a moral compass - it is a recipe for business success." First and foremost, J&J serves patients and medical professionals by providing high quality, reasonably priced products, and services.
We are also always conscious of our obligations to both our employees and the communities we serve.
Our final responsibility is to deliver fair profits to our stockholders by remaining innovative as well as fiscally sound.
Please click here for the J&J Credo. Pharmaceuticals Research & Development At Johnson & Johnson Pharmaceutical R&D, we are committed to translating breakthrough science into medicines that make a difference in the lives of patients, their families, their communities, and the health care ecosystem. We are constantly working to maximize our internal scientific excellence and seek to partner with the best external science available globally.
Through this approach, we have become the industry leader in productivity, FDA approvals and breakthrough designations, with 13 new products since 2011 and most NME approvals 2011-2016.
We are also one of the fastest growing and most admired pharmaceutical companies. We have a strong and ever-evolving discovery organization with labs around the world including in Spring House, PA, Beerse, Belgium, Leiden, The Netherlands, Beijing and Shanghai, China, La Jolla and Cambridge, MA.
More than 15 new compounds are typically advanced per year into development.
We also have one of the very strongest development organizations in the world, committed to working with regulators to progress meaningful medicines, evolving endpoints as needed, using modern and innovative approaches to clinical operations and trial design.
We remain committed to our products after they enter the marketplace, continue to support their evolution within the approved indications and explore their value and suitability in new indications. ROLE OVERVIEW : Johnson & Johnson is recruiting for a Vice President, Head of Neurodegeneration Development to be based at one of our sites in Titusville, NJ; Cambridge, MA; Spring House, PA; La Jolla, CA; Alschwil, CH; or Beerse, BE. The Development Head (DH) is responsible for all late development activities within the Neurodegeneration Disease Area (ND) -which includes neuroinflammation-and reports to the Global Head of Development for Neuroscience.
In this role, the DH provides global leadership and direction to clinical research staff within ND and directly manages late phase compound development team leaders (CDTLs) and physicians..
The DH assigns or provides needed clinical support and consultation for projects related to their discipline outside of the TA, across J&J and for other Janssen R&D companies.
Working with his or her functional partners, the DH plays a key role in the development and execution of the Therapeutic Area and Disease Area strategies. RESPONSIBILITIES :
- Core member of the Disease Area Leadership Team (DALT) and the Neuroscience Development Leadership Team
- The DH has responsibility for the ND development strategy in alignment with Disease Area Strategies, and for the appropriate and for assuring an integrated, efficient, effective and timely implementation of that strategy.
- The DH ensures that CDTs develop thoughtful, integrated asset development strategies and appropriately capture these in the Asset Development Plan document.
Helping teams identify and addresses the key issues, alternative strategies considered, and key stages of development (with associated GO / NO GO decision points and criteria).
He or she may delegate some of these responsibilities, as appropriate.
In this role, the DH will work with the CDTL and with functional partners from global medical affairs, health care compliance, legal regulatory, and other relevant groups.
The GDH is accountable for business plans (BPs) and executing according to the business plans.
Candidates hired outside the United States will be eligible for compensation and benefits in accordance with their local market. Employees may be eligible to participate in Company employee benefit programs such as health insurance, savings plan, pension plan, disability plan, long term incentives, vacation pay, sick time, holiday pay, and work, personal and family time off in accordance with the terms of the applicable plans.
Additional information can be found through the link below.
For additional general information on Company benefits, please go to : - https : / / www.careers.jnj.com / employee-benefits . Johnson & Johnson is an Affirmative Action and Equal Opportunity Employer.
All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, or protected veteran status and will not be discriminated against based on disability .
For more information on how we support the whole health of our employees throughout their wellness, career and life journey, please visit www.careers.jnj.com.
Salary : $253,000 - $465,750
